The Japanese Patent Office has signalled its intention to grant patent protection for bioAffinity Technologies’ noninvasive ...

Houston clinics now offer a blood test that looks for signals of more than 50 cancers, but doctors say it does not replace ...

IWK Health becomes first site in Nova Scotia to join Breathe BioMedical's multi-center study to advance development of its technology for early detection of breast cancer in women Moncton, New ...

A comprehensive new review in Neural Computing and Applications charts how machine learning and deep learning are ...

Researchers have built the first spatial atlas of dermal backflow in breast cancer-related lymphedema from 282 patients and ...

The team complemented this approach with another technique called Raman spectroscopy (SERS), to gather chemical information ...

Affinity Technologies (Nasdaq: BIAF) soars after the Japan Patent Office issues a Notice of Allowance for its CyPath Lung ...

Scientists have found solutions to two major problems associated with the treatment of cancer: recurrence and damage to ...

SAN ANTONIO, October 08, 2026--bioAffinity Technologies receives notice of allowance for new patent in Japan covering its noninvasive CyPath Lung diagnostic test for lung cancer.

A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.

A new House resolution led by Representative Don Bacon (R-NE) would designate October 15, 2026, as Liver Cancer Awareness Day, elevating a disease expected to claim nearly 31,000 U.S. lives this year ...

A new study from Mayo Clinic researchers suggests that an AI model could use routine electronic health records and laboratory ...